T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis

Journal of Experimental Medicine

Volumn 184, Issue 5, 1996, Pages 1791-1800

  Scotet, Emmanuel ^a   David Ameline, Jacques ^a   Peyrat, Marie Alix ^a   Moreau Aubry, Agnès ^a   Pinczon, Delphine ^a   Lim, Annick ^b   Even, Jos ^b   Semana, Gilbert ^c   Berthelot, Jean Marie ^d   Breathnach, Richard ^a   Bonneville, Marc ^a   Houssaint, Elisabeth ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b INSTITUT PASTEUR   (France)

^c Centre Regional de Transfusion Sanguine   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PREDNISONE; RNA; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; VIRUS ANTIGEN;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; CELL CLONE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONKEY; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TRANSACTIVATION; VIRUS REACTIVATION;

EID: 10544238102     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.5.1791     Document Type: Article

References (44)

1. Harris, E.D. 1990. Rheumatoid arthritis: pathophysiology and implications for therapy. N. Engl. J. Med. 322:1277-1289.
2. Van Boxel, J.A., and S.A. Paget. 1975. Predominantly T-cell infiltrate in rheumatoid synovial membrane. N. Engl. J. Med. 293:517-520.
3. McMichael, A.J., K. Sasazuki, H.O. McDevitt, and R.O. Payne. 1977. Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum. 20:1037-1042.
4. Statsny, P. 1978. Association of the B-cell alloantigen Drw4 with rheumatoid arthritis. N. Engl. J. Med. 298:869-871.
5. Legrand, L., G.M. Lathrop, A. Marcelli-Barge, A. Dryll, T. Bardin, N. Debeyre, J.C. Poirier, M. Schmidt, A. Ryckewaert, and J. Dausset. 1984. HLA-DR genotype risks in seropositive rheumatoid arthritis. Am. J. Hum. Genet. 36:690-699.
6. Zoschke, D., and M. Segall. 1986. Dw subtypes of DR4 in rheumatoid arthritis: evidence for a preferential association with Dw4. Hum. Immunol. 15:118-124.
7. Weyand, C.M., K.C. Hicock, D.L. Conn, and J.J. Goronzy. 1992. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann. Intern. Med. 117:801-806.
8. Herzog, C.H., C. Walker, W. Pichler, A. Aeschlimann, P. Wassmer, H. Stockinger, W. Knapp, P. Rieber, and W. Muller. 1987. Monoclonal anti-CD4 in arthritis. Lancet. 2: 1461-1462.
9. Yocum, D.E., J.H. Klippel, R.L. Wilder, N.L. Gerber, H.A. Austin, S.M. Wahl, L. Lesko, J.R. Minor, H.G. Preuss, and C. Yarboro. 1989. Cyclosporin A in severe treatment refractory rheumatoid arthritis. A randomized study. Ann. Intern. Med. 109:863-869.
10. Londei, M., C.M. Savill, A. Verhoef, F. Brennan, Z.A. Leech, V. Duance, R.N. Maini, and M. Feldmann. 1989. Persistence of collagen type II-specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 86:636-640.
11. Trentham, D.E., R.E. Dynesius, R. Rocklin, and J.R. David. 1976. Cellular sensitivity to collagen in rheumatoid arthritis. N. Engl. J. Med. 229:327-332.
12. Holoshitz, J., A. Klajman, I. Drucker, Z. Lapidot, A. Yaretzky, A. Frenkel, W. van Eden, and I.R. Cohen. 1986. T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a traction of mycobacteria cross-reactive with cartilage. Lancet. 2:305-309.
13. Res, P.C.M., C.G. Shaar, F.C. Breedveld, W. van Eden, J.D.A van Embden, I.R. Cohen, and R.R.P. de Vries. 1988. Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet. 2:478-480.
14. Gaston, J.S.H., P.F. Life, P.J. Jenner, M.J. Colston, and P.A. Bacon. 1990. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J. Exp. Med. 171:831-841.
15. Fischer, H.P., C.E.M. Sharrock, M.J. Colston, and G.S. Panayi. 1991. Limiting dilution analysis of proliferative T cell responses to mycobacterial 65 kDa heat-shock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis. Eur. J. Immunol. 21:29-37.
16. Lotz, M., and J. Roudier. 1992. Epstein-Barr virus and rheumatoid arthritis. In Rheumatoid Arthritis. E. Smolen, J. Kalden, and R.N. Maini, editors. Springer Verlag, Berlin. 257-280.
17. Fox, R.I., M. Luppi, P. Pisa, and H.I. Kang. 1992. Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis. J. Rheumatol. 19:18-24.
18. Struyk, L., G.E. Hawes, M.K. Chatila, F.C. Breedveld, J.T. Kurnick, and P.J. van den Elsen. 1995. T cell receptors in rheumatoid arthritis. Arthritis Rheum. 38:577-589.
19. Koopman, W.J. 1994. The future of biologies in the treatment of rheumatoid arthritis. Semin. Arthritis Rheum. 23:50-58.
20. David-Ameline, J., A. Lim, F. Davodeau, M.A. Peyrat, J.M. Berthelot, O. Semana, C. Pannetier, J. Gaschet, H. Yié, J. Even, and M. Bonneville. 1996. Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis. J. Immunol. In press.
21. Arnett, E.G., S.M. Edworthy, P.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, L.A. Healey, S.R. Kaplan, M.H. Liang, H.S. Luthra et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315-324.
22. Vié, H., S. Chevalier, R. Garand, J.P. Moisan, V. Praloran, M.C. Devilder, J.F. Moreau, and J.P. Soulillou. 1989. Clonal expansion of lymphocytes bearing the gamma/delta receptor in a patient with a large granular lymphocyte disorder. Blood. 74:285-292.
23. Brichard, V., A. van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
24. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA. 84:3365-3369.
25. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, tor measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
26. Wong, K.M., and A.J. Levine. 1986. Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans. J. Virol. 60: 149-156.
27. Wong, K.M., and A.J. Levine. 1989. Characterization of proteins encoded by the Epstein-Barr virus transactivator gene BMLF1. Virology. 168:101-111.
28. Rammensee, H.G., T. Friede, and I. Stevanovic. 1995. MHC ligands and peptides: first listing. Immunogenetics. 41: 178-228.
29. Chevallier-Greco, A., E. Manet, P. Chavrier, C. Mosnier, J. Daillie, and A. Sergeant. 1986. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO (Eur. Mol. Biol. Organ.) J. 5:3243-3249.
30. Rickinson, A.B., and E. Kieff. 1996. Epstein-Barr virus. In Fields Virology. B.N. Fields, D.M. Knipe, P.M. Howley et al., editors. Raven Press, Philadelphia, PA. 2397-2446.
31. Firestein, G.S., and N.J. Zvaifler. 1990. How important are T tells in chronic rheumatoid arthritis? Arthritis Rheum. 33: 768-773.
32. Zhang, L., S. Nikkari, and M. Skurnik. 1993. Detection of herpes viruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum. 36: 1080-1086.
33. Brousset, P., M. Caulier, A. Cantagrel, C. Dromer, B. Mazières, and G. Delsol. 1993. Absence of Epstein-Barr virus carrying cells in synovial membranes and subcutaneous nodules of patients with rheumatoid arthritis. Ann. Rheum. Dis. 52:608-609.
34. Newkirk, M.M., K.N. Watanabe Duffy, J. Leclerc, N. Lambert, and J.B. Shiroky. 1994. Detection of cytomegalovirus, Epstein-Barr virus and Herpes virus-6 in patients with rheumatoid arthritis with or without Sjögren's syndrome. Br. J. Rheumatol. 33:317-322.
35. Venables, P.J.W. 1988. Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis. Ann. Rheum. Dis. 47: 265-269.
36. Rhodes, G., H. Rumpold, P. Kurki, K.M. Patrick, D.A. Carson, and J.H. Vaughan. 1987. Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. J. Exp. Med. 165:1026-1040.
37. Fox, R.I., R. Sportsman, G.H. Rhodes, J. Luke, G. Pearson, and J.H. Vaughan. 1986. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus encoded EBNA-1 antigen. J. Clin. Invest. 77:1539-1547.
38. Roudier, J., G. Rhodes, J. Petersen, J.H. Vaughan, and D.A. Carson. 1988. The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1 and rheumatoid arthritis. Scand. J. Immunol. 27:367-371.
39. Alspaugh, M.A., G. Henle, E.T. Lennette, and W. Henle. 1981. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J. Clin. Invest. 67:1134-1140.
40. Venables, P.J.W. 1992. Antibodies to EBV-encoded proteins in rheumatoid arthritis. In Rheumatoid Arthritis. E. Smolen, J. Kalden, and R.N. Maini, editors. Springer-Verlag, Berlin. 281-295.
41. Bardwick, P.A., H.G. Bluestein, N.J. Zvaifler, J. Depper, and J. Seegmiller. 1979. Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum. 23:626-632.
42. Tosato, G., A.D. Steinberg, and R.M. Blaese. 1981. Defective EBV-specific suppressor T cell function in rheumatoid arthritis. N. Engl. J. Med. 305:1238-1243.
43. Kieff, E. 1996. Epstein-Barr virus and its replication. In Fields Virology. B.N. Fields, D.M. Knipe, P.M. Howley et al. Raven Press. Philadelphia. 2343-2395.
44. Lacerda, J.F., M. Ladanyi, D.C. Louie, J.M. Fernandez, E.B. Papadopoulos, and R. O'Reilly. 1996. Human EBV-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B.-17 scid/scid mice. J. Exp. Med. 183:1215-1228.